RICHMOND, Va.--(BUSINESS WIRE)--Nov. 22, 2005--Commonwealth Biotechnologies, Inc. (CBI) (NASDAQ: CBTE), today announced that Joseph R. Slay has been appointed to its Board of Directors and will be seated at the first quarter Board meeting in 2006. Slay will stand for ratification by shareholders at the Company's 2006 annual meeting. CBI is also announcing the resignation of Peter Einselen, effective immediately, who has served on the Board since 2003. Einselen opted to resign to focus on his primary business activities as a broker for Anderson and Strudwick, Inc., a regional firm headquartered in Richmond, Virginia.
